"An investment in knowledge pays the best interest."


Diagnos Inc. (ADK.V) has won a contract award for a strategic initiative in Latin America to screen a large population of diabetics by Dec. 31, 2016. Under the final agreement, it is expected that Diagnos will receive a 40-per-cent deposit on the total amount and a monthly payment until Dec. 31, 2016. Diagnos is working closely with the customer to identify the requirements for an additional two years of services.

According to the International Diabetes Federation, this country, ranked sixth worldwide in number of people with diabetes, second in adult obesity and first in child obesity, is taking the lead to reverse these unfavourable health trends by investing in prevention and education.

In the last 20 years, the client has spent more than $1.2-billion (U.S.) treating complications from diabetes which could have been avoided by implementing wellness programs. Blindness is one major complication that has a huge impact on families and society. The objective is now to unburden the economic load by preventing up to 85 per cent of blindness cases and delivering an accessible service of the highest quality.

“Our commitment is to assist the National Diabetes Program via a mass screening project aimed at reducing the cost of diabetes and preventing vision loss in its population. After four years of experience deploying screening projects in many countries including India, the United Arab Emirates, Algeria, Poland, Canada, the United States, Colombia, Mexico, we’re highly committed to adding value to this program by offering comprehensive services. The uniqueness the Diagnos technology platform CARA (computer-assisted retinal analysis) in terms of image processing and enhancement enables for faster referral to specialists,” said Andre Larente, president of Diagnos.